magnesium for aneurysmal subarachnoid haemorrhage (mash-2): a randomised placebo-controlled trial...
TRANSCRIPT
![Page 1: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,](https://reader033.vdocuments.us/reader033/viewer/2022051614/551b1f4b550346cf5a8b5762/html5/thumbnails/1.jpg)
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial
Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M
van den Bergh, MD and on behalf of the MASH-2 study group
The LancetVolume 380, Issue 9836, Pages 44-49 (July 2012)
DOI: 10.1016/S0140-6736(12)60724-7
Copyright © 2012 Elsevier Ltd Terms and Conditions
![Page 2: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,](https://reader033.vdocuments.us/reader033/viewer/2022051614/551b1f4b550346cf5a8b5762/html5/thumbnails/2.jpg)
Figure 1
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
![Page 3: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,](https://reader033.vdocuments.us/reader033/viewer/2022051614/551b1f4b550346cf5a8b5762/html5/thumbnails/3.jpg)
Figure 2
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
![Page 4: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,](https://reader033.vdocuments.us/reader033/viewer/2022051614/551b1f4b550346cf5a8b5762/html5/thumbnails/4.jpg)
Figure 3
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
![Page 5: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,](https://reader033.vdocuments.us/reader033/viewer/2022051614/551b1f4b550346cf5a8b5762/html5/thumbnails/5.jpg)
Figure 4
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions